Andrew Bowser
Andrew Bowser is a medical writer based in Brooklyn, New York.
Tough Stuff
New York - For severe forms of psoriasis, dermatologists should choose treatments based on efficacy and rapidity of response more so than potential for chronic toxicities, according to Kenneth B. Gordon, M.D.
Tried and (Still) True
New York - Even as biologic therapies become available, there will still be a place for acitretin, methotrexate and cyclosporin-based treatment protocols, according to Mark Lebwohl, M.D.
Psychology of psoriasis keys compliance
New York - For treatment of localized psoriasis, breaking down the barriers to compliance can begin with something as simple as the human touch, according to Steven R. Feldman, M.D., Ph.D., director, Psoriasis Treatment Center, Wake Forest University School of Medicine, Winston-Salem, N.C.
Therapy Pearls
Various options, combinations improve scalp, palmar, and plantar lesions

Physician: Alan Menter, M.D.

UVB Options
Excimer laser, fiber-optic modalities effective in less time

Physician: Henry W. Lim, M.D.

Lipid-lowering drugs may prevent, treat melanoma
Los Angeles - The use of lipid-lowering drugs may inhibit the development of melanoma, according to results of two separate studies presented at the annual meeting of the Society for Investigative Dermatology.
Vaccine could boost survival for node-negative melanoma
Ann Arbor, Mich. - An allogeneic melanoma vaccine - Melacine, made by Corixa Corp. - might provide a survival benefit in node-negative melanoma patients expressing specific HLA class I antigens, according to recent reports.
Methyl aminolevulinate treatment less painful for AK, BCC patients
Los Angeles - Photodynamic therapy using a derivative of 5-aminolevulinic acid hydrochloride (5-ALA) provides a significantly higher clinically efficacy and cosmetic result versus cryotherapy for treatment of actinic keratosis, according to Paul S. Yamauchi, M.D., Ph.D.
Cholesterol in keratinocytes may be photoprotective
Los Angeles - Cholesterol, in keratinocytes, has the capacity to prevent ultraviolet A (UVA) radiation-induced gene expression, according to results of research conducted by German researcher Jean Krutmann, M.D., and colleagues.
Fluconazole Tx for cutaneous leishmaniasis
Riyadh, Saudi Arabia - For treatment of cutaneous leishmaniasis caused by Leishmania major, a six-week course of oral fluconazole is effective and avoids the potentially severe side effects of standard parenteral therapy, according to Abdulrahman A. Alrajhi, M.D., M.P.H.


View Results